About PERFuse

PERFuse is the first commercially available technology that will inform surgeons already during surgery about the risk of an AL, subsequently allowing the surgeon to undertake preventive measures in an early stage. By automating the calculation of the risk-index, results can be obtained already within one minute, making the device also suitable for emergency cases.


Why PERFuse?


Quantitive assessment of risk leakage --> 89 % Positive Predictive Value.



Easy to use, no special training required, clear IFU. 

Easy to embed in all current operation protocols without changing procedure. 


Measurement obtained within minutes


The probe will be disposable, small and lightweight

© 2019 Brightlands Maastricht Health Campus • All rights reserved